Losartan more effective than atenolol in hypertension with left ventricular hypertrophy

Affiliations

Comment

Lynda Montgomery. J Fam Pract. 2002 Jul.

. 2002 Jul;51(7):599.

¹ Department of Family Medicine, Boston University School of Medicine, Boston, MA, USA. Lynda.Montgomery@bmc.org

No abstract available

Comment on

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H; LIFE Study Group. Dahlöf B, et al. Lancet. 2002 Mar 23;359(9311):995-1003. doi: 10.1016/S0140-6736(02)08089-3. Lancet. 2002. PMID: 11937178 Clinical Trial.